Ethyl pyruvate downregulates tumor necrosis factor alpha and interleukin (IL)-6 and upregulates IL-10 in lipopolysaccharide-stimulated canine peripheral blood mononuclear cells

Journal of Veterinary Medical Science

Volumn 72, Issue 10, 2010, Pages 1379-1381

  Yu, Do Hyeon ^a   Noh, Dong Ho ^a   Song, Ru Hui ^a   Park, Jinho ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Canine peripheral blood mononuclear cells; Cytokine; Ethyl pyruvate; mRNA

Indexed keywords

FLAVORING AGENT; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; DOG; DOWN REGULATION; DRUG EFFECT; GENETICS; MONONUCLEAR CELL; PHYSIOLOGY; UPREGULATION;

ANIMALS; DOGS; DOWN-REGULATION; FLAVORING AGENTS; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PYRUVATES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

CANIS FAMILIARIS;

EID: 78249246362     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.09-0590     Document Type: Article

References (11)

1. Das, U. N. 2006. Is pyruvate an endogenous anti-inflammatory molecule? Nutrition 22: 965-972.
2. Fink, M. P. 2002. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution. Curr. Opin. Clin. Nutr. Metab. Care 5: 167-174.
3. Gewert, K., Svensson, U., Andersson, K., Holst, E. and Sundler, R. 1999. Dexamethasone differentially regulates cytokine transcription and translation in macrophages responding to bacteria or okadaic acid. Cell Signal. 11: 665-670.
4. Livak, K. J. and Schmittgen, T. D. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
5. Mallet, R. T. and Sun, J. 2003. Antioxidant properties of myocardial fuels. Mol. Cell Biochem. 253: 103-111.
6. Raabe, T., Bukrinsky, M. and Currie, R. A. 1998. Relative contribution of transcription and translation to the induction of tumor necrosis factor-alpha by lipopolysaccharide. J. Biol. Chem. 273: 974-980.
7. Sims, C. A., Wattanasirichaigoon, S., Menconi, M. J., Ajami, A. M. and Fink, M. P. 2001. Ringer's ethyl pyruvate solution ameliorates ischemia/reperfusion-induced intestinal mucosal injury in rats. Crit. Care Med. 29: 1513-1518.
8. Tawadrous, Z. S., Delude, R. L. and Fink, M. P. 2002. Resuscitation from hemorrhagic shock with Ringer's ethyl pyruvate solution improves survival and ameliorates intestinal mucosal hyperpermeability in rats. Shock 17: 473-477.
9. Ulloa, L. and Messmer, D. 2006. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine. Growth Factor Rev. 17: 189-201.
10. Ulloa, L., Ochani, M., Yang, H., Tanovic, M., Halperin, D., Yang, R., Czura, C. J., Fink, M. P. and Tracey, K. J. 2002. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc. Natl. Acad. Sci. U.S.A. 99: 12351-12356.
11. Yang, R., Gallo, D. J., Baust, J. J., Uchiyama, T., Watkins, S. K., Delude, R. L. and Fink, M. P. 2002. Ethyl pyruvate modulates inflammatory gene expression in mice subjected to hemorrhagic shock. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G212-221.